Skip to main content
SpringerLink
Account

Table 2 Intraperitoneal route of administration of three different concentrations for each Biogenic nanoparticles: experiment (B)

From: A Comparative In Vivo Scrutiny of Biosynthesized Copper and Zinc Oxide Nanoparticles by Intraperitoneal and Intravenous Administration Routes in Rats

Group II: Bio-CuNP (μg/kg)

Group III: Bio-ZnONPs (μg/kg)

Group B (NOAEC) 13.41

Group B (NOAEC) 24.8

Group C (IC50) 16.75

Group C (IC50) 27.2

Group D (TLC) 19.82

Group D (TLC) 30.3

  1. NOAEC “no observable adverse effect concentration”, IC 50 inhibitory concentration, TLC total lethal concentration
Back to article page

Search

Navigation